Review
Primary hyperparathyroidism: pathophysiology and impact on bone
Aliya Khan and John Bilezikian
CMAJ July 25, 2000 163 (2) 184-187;
Aliya Khan
Dr. Khan is Associate Clinical Professor of Medicine, McMaster University, Hamilton, Ont., and Dr. Bilezikian is Professor of Medicine, Columbia University College of Physicians and Surgeons, New York, NY.
John Bilezikian
Dr. Khan is Associate Clinical Professor of Medicine, McMaster University, Hamilton, Ont., and Dr. Bilezikian is Professor of Medicine, Columbia University College of Physicians and Surgeons, New York, NY.
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article tools
Primary hyperparathyroidism: pathophysiology and impact on bone
Aliya Khan, John Bilezikian
CMAJ Jul 2000, 163 (2) 184-187;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Sirtuin 1 Is a Negative Regulator of Parathyroid Hormone Stimulation of Matrix Metalloproteinase 13 Expression in Osteoblastic Cells: ROLE OF SIRTUIN 1 IN THE ACTION OF PTH ON OSTEOBLASTS
- Diagnosis and management of primary hyperparathyroidism
- Hypocalcemia: Updates in diagnosis and management for primary care
- Hypocalcemie: Mises a jour dans le diagnostic et la prise en charge en soins primaires
- Primary hyperparathyroidism
- Primary hyperparathyroidism: Update on presentation, diagnosis, and management in primary care
- Case Report: Celiac Disease Masquerading As Bone Metastasis in a 29-Year-Old Woman
- The risk of fractures in postmenopausal women with primary hyperparathyroidism
- Association of low 25-hydroxyvitamin D concentrations with elevated parathyroid hormone concentrations and low cortical bone density in early pubertal and prepubertal Finnish girls
- Musculoskeletal case 27. Diagnosis
- Asymptomatic hyperparathyroidism: Is the pendulum swinging back?